Follow
Anuraag R. Kansal
Anuraag R. Kansal
GRAIL
Verified email at grailbio.com
Title
Cited by
Cited by
Year
Simulated brain tumor growth dynamics using a three-dimensional cellular automaton
AR Kansal, S Torquato, GR Harsh, EA Chiocca, TS Deisboeck
Journal of theoretical biology 203 (4), 367-382, 2000
5832000
Pattern of self‐organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model
TS Deisboeck, ME Berens, AR Kansal, S Torquato, ...
Cell Proliferation 34 (2), 115-134, 2001
2642001
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective
SV Sorensen, AR Kansal, S Connolly, S Peng, J Linnehan, ...
Thrombosis and haemostasis 105 (05), 908-919, 2011
2592011
Diversity of order and densities in jammed hard-particle packings
AR Kansal, S Torquato, FH Stillinger
Physical Review E 66 (4), 041109, 2002
2392002
Computer generation of dense polydisperse sphere packings
AR Kansal, S Torquato, FH Stillinger
The Journal of chemical physics 117 (18), 8212-8218, 2002
2092002
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
AR Kansal, SV Sorensen, R Gani, P Robinson, F Pan, JM Plumb, ...
Heart 98 (7), 573-578, 2012
1422012
Cellular automaton of idealized brain tumor growth dynamics
AR Kansal, S Torquato, GR Harsh Iv, EA Chiocca, TS Deisboeck
Biosystems 55 (1-3), 119-127, 2000
1402000
Emergence of a subpopulation in a computational model of tumor growth
AR Kansal, S Torquato, EA Chiocca, TS Deisboeck
Journal of Theoretical Biology 207 (3), 431-441, 2000
1282000
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
F Skjøth, TB Larsen, LH Rasmussen, GYH Lip
Thrombosis and haemostasis 112 (05), 981-988, 2014
1242014
Nonequilibrium hard-disk packings with controlled orientational order
AR Kansal, TM Truskett, S Torquato
The Journal of Chemical Physics 113 (12), 4844-4851, 2000
772000
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada
AR Kansal, M Sharma, C Bradley-Kennedy, A Clemens, BU Monz, ...
Thrombosis and haemostasis 108 (10), 672-682, 2012
762012
Defining virtual patient populations
C Friedrich, A Kansal, D Klinke, S Michelson, T Paterson, D Polidori, ...
US Patent App. 11/346,990, 2007
622007
Comparison of the cost-effectiveness of new oral anticoagulants for the prevention of stroke and systemic embolism in atrial fibrillation in a UK setting
Y Zheng, SV Sorensen, AK Gonschior, H Noack, J Heinrich-Nols, ...
Clinical therapeutics 36 (12), 2015-2028. e2, 2014
552014
Modeling approaches to type 2 diabetes
AR Kansal
Diabetes technology & therapeutics 6 (1), 39-47, 2004
552004
A cellular automaton model of brain tumor treatment and resistance
JE Schmitz, AR Kansal, S Torquato
Journal of Theoretical Medicine 4 (4), 223-239, 2002
552002
Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK
A Hackshaw, SS Cohen, H Reichert, AR Kansal, KC Chung, JJ Ofman
British Journal of Cancer 125 (10), 1432-1442, 2021
522021
Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation
AR Kansal, Y Zheng, T Pokora, SV Sorensen
Best Practice & Research Clinical Haematology 26 (2), 225-237, 2013
442013
Cost‐effectiveness analysis of empagliflozin treatment in people with Type 2 diabetes and established cardiovascular disease in the EMPA‐REG OUTCOME trial
A Kansal, OS Reifsnider, I Proskorovsky, Y Zheng, E Pfarr, JT George, ...
Diabetic Medicine 36 (11), 1494-1502, 2019
352019
Cost‐effectiveness of ivabradine for heart failure in the United States
AR Kansal, MR Cowie, A Kielhorn, S Krotneva, A Tafazzoli, Y Zheng, ...
Journal of the American Heart Association 5 (5), e003221, 2016
352016
Application of predictive biosimulation within pharmaceutical clinical development: examples of significance for translational medicine and clinical trial design
AR Kansal, J Trimmer
IEE Proceedings-Systems Biology 152 (4), 214-220, 2005
352005
The system can't perform the operation now. Try again later.
Articles 1–20